ORCHARD THERAPEUTICS PLC's ticker is ORTX and the CUSIP is 68570P101. A total of 1 filers reported holding ORCHARD THERAPEUTICS PLC in Q2 2024. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $477,000 | -42.7% | 361,736 | 0.0% | 0.01% | -50.0% |
| Q3 2021 | $832,000 | +103.4% | 361,736 | +542.5% | 0.01% | +55.6% |
| Q1 2021 | $409,000 | -87.1% | 56,297 | -92.3% | 0.01% | -89.3% |
| Q4 2020 | $3,177,000 | +363.1% | 735,455 | +340.6% | 0.08% | +281.8% |
| Q3 2020 | $686,000 | -60.9% | 166,909 | -42.9% | 0.02% | -68.1% |
| Q2 2020 | $1,754,000 | -60.6% | 292,250 | -50.6% | 0.07% | -78.3% |
| Q1 2020 | $4,452,000 | +187.2% | 591,250 | +424.4% | 0.32% | +404.8% |
| Q4 2019 | $1,550,000 | – | 112,756 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CHI Advisors LLC | 2,931,185 | $17,587,000 | 6.86% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 7,259,988 | $43,560,000 | 1.27% |
| RA Capital Management | 10,403,187 | $45,688,000 | 0.89% |
| REGENTS OF THE UNIVERSITY OF CALIFORNIA | 851,201 | $5,107,000 | 0.72% |
| Casdin Capital, LLC | 1,650,000 | $9,900,000 | 0.59% |
| Vivo Capital, LLC | 1,325,736 | $7,954,000 | 0.57% |
| Bleichroeder LP | 125,200 | $751,000 | 0.13% |
| Virtus ETF Advisers LLC | 45,787 | $275,000 | 0.13% |
| Forefront Analytics, LLC | 19,130 | $115,000 | 0.07% |
| Woodline Partners LP | 292,250 | $1,754,000 | 0.07% |